703675000: Dapagliflozin propanediol (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with cellular transport inhibitor mechanism of action (substance)\Sodium glucose cotransporter subtype 2 inhibitor\Dapagliflozin propanediol (substance)

\Drug or medicament (substance)\Dapagliflozin propanediol (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure\Organic compound\Substance with ether structure (substance)\Dapagliflozin propanediol (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3009016015 Dapagliflozin propanediol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3009811014 Dapagliflozin propanediol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3009016015 Dapagliflozin propanediol en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3009016015 Dapagliflozin propanediol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3009811014 Dapagliflozin propanediol (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3009811014 Dapagliflozin propanediol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dapagliflozin propanediol (substance)	Is a	Dapagliflozin (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Dapagliflozin propanediol (substance)	Has disposition	Sodium glucose cotransporter subtype 2 inhibitor (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Dapagliflozin propanediol (substance)	Is modification of (attribute)	Dapagliflozin (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Dapagliflozin propanediol (substance)	Is a	Sodium glucose cotransporter subtype 2 inhibitor	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Dapagliflozin propanediol (substance)	Is a	Substance with ether structure (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Dapagliflozin propanediol (substance)	Is a	Drug or medicament (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely dapagliflozin propanediol 5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely dapagliflozin propanediol 10 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely dapagliflozin propanediol 5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dapagliflozin propanediol 5 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dapagliflozin propanediol 10 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dapagliflozin propanediol 10 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dapagliflozin propanediol 5 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dapagliflozin propanediol 10 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dapagliflozin propanediol monohydrate (substance)	Is modification of (attribute)	True	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely dapagliflozin (as dapagliflozin propanediol monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dapagliflozin (as dapagliflozin propanediol) 10 mg oral tablet	Has precise active ingredient	True	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dapagliflozin propanediol anhydrous	Is modification of (attribute)	True	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Dapagliflozin (as dapagliflozin propanediol) 5 mg and metformin hydrochloride 850 mg oral tablet	Has precise active ingredient	True	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 10 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Dapagliflozin propanediol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2

Reference Sets

Description inactivation indicator reference set